Best Time to Inject GLP-1 Peptides
The Short Answer
Timing Recommendations by Peptide
| Peptide | Half-Life | Recommended Timing |
|---|---|---|
| Retatrutide | ~6 days | Same day each week — morning or evening fine |
| Tirzepatide | ~5 days | Same day each week — with or without food |
| Semaglutide | ~7 days | Same day each week — anytime |
Practical Tips
- T-01
Set a weekly reminder
Choose a day that works (e.g. Monday morning) and set a recurring phone reminder.
- T-02
Inject before bed to manage nausea
Some users prefer evening injection so initial nausea (most common in first 1–2 hours) occurs during sleep.
- T-03
Food timing is flexible
Unlike some medications, GLP-1 agonists can be taken with or without food. Absorption is subcutaneous and not affected by meals.
- T-04
If you miss a day
Inject as soon as you remember if within 5 days of your scheduled dose. If more than 5 days, skip and resume your normal schedule the following week.
Manila timing realities
On the ground in the Philippines
The half-life math is universal — what changes in Manila is the schedule wrapping it. Most users running GLP-1 protocols here pick Sunday evening as their fixed weekly slot. The reasoning is operational, not pharmacological: traffic in Metro Manila collapses Sunday after 8pm, the fridge is restocked from the weekend grocery run, and any peak-nausea window (12–24 hours after injection) lands during the Monday work-from-home buffer that's become standard at most BGC and Makati employers post-2024. Hospital pharmacy hours at Makati Medical Center, St. Luke's BGC, and The Medical City are easier on weekends if a refill is needed.
On heat: cold chain matters more here than in temperate climates. Manila averages 30–34°C year-round with humidity above 70 percent. Pre-filled GLP-1 pens (Ozempic, Mounjaro) sourced through Mercury Drug or Watsons are stable refrigerated and tolerate room temperature for the duration listed on the label, but a pen left on a kitchen counter through a brownout in Quezon City for six hours is a different story. Inject within 15 minutes of removing from the fridge — don't leave the dose-loaded pen out while you finish a meal. Same applies to reconstituted research-grade vials of retatrutide or tirzepatide stored at home.
On consistency: setting the recurring reminder on a Philippine SIM-issued phone is the same as anywhere, but if you travel for work to Cebu, Davao, or out of the country, the time-zone math is irrelevant for weekly dosing — you're injecting on the same calendar day, not the same clock hour. The 5-day rule on missed doses still applies: if you're back in Manila on day 4, inject. Day 6, skip and resume the following Sunday.
Sunday-night protocol log
My experience
I've been on tirzepatide since November 2025. Started 2.5mg, titrated to 7.5mg by week 16, currently holding at 10mg. My fixed weekly slot is Sunday 9pm — picked it after the third week when I figured out the nausea pattern. Injection at 9pm Sunday, peak nausea hits around 9am Monday, gone by Monday afternoon. I work from home on Mondays so the timing is operationally clean.
Two specific things I learned the hard way. First, the cold-chain matters more than I thought. In February 2026 I left a pre-filled Mounjaro pen on the kitchen counter in my BGC condo for about four hours during a brownout — outside fridge, ambient temp probably 32–33°C. Injected anyway. The dose felt blunted that week, scale didn't move, hunger came back midweek. Switched the next injection to a fresh pen, normal response resumed. Anecdotal but I now treat the 15-minute counter window as an actual rule, not a suggestion.
Second: I missed an injection in late March 2026 when I was in Cebu for a wedding. Day 4 after the missed dose I was back in Manila and dosed at the original Sunday-evening time (which was actually a Thursday by then). Didn't shift the schedule. The 5-day rule held — no rebound nausea, no efficacy drop. The rule is not a suggestion, it's clinically grounded in the half-life data.
What this guide doesn't replace
Risks & honest disclaimer
Pharmacokinetics and label data
Sources
- SRC-01Jastreboff AM et al. Tirzepatide once weekly for the treatment of obesity. NEJM 2022;387:205–216. DOI: 10.1056/NEJMoa2206038 · PubMed: 35658024 — pivotal trial establishing tirzepatide pharmacokinetics, ~5-day terminal half-life, and weekly-dosing rationale.
- SRC-02Jastreboff AM et al. Triple–hormone-receptor agonist retatrutide for obesity (Phase 2). NEJM 2023;389:514–526. DOI: 10.1056/NEJMoa2301972 · PubMed: 37366315 — retatrutide pharmacokinetics with ~6-day half-life supporting weekly dosing.
- SRC-03Wilding JPH et al. Once-weekly semaglutide in adults with overweight or obesity. NEJM 2021;384:989–1002. DOI: 10.1056/NEJMoa2032183 · PubMed: 33567185 — semaglutide ~7-day half-life and weekly schedule.
- SRC-04FDA Philippines Verification Portal. verification.fda.gov.ph — registered drug products database, used to confirm Ozempic, Wegovy, and Mounjaro PH registration status.
- SRC-05Mounjaro (tirzepatide) Prescribing Information, Eli Lilly. Section 2.4: missed dose — within 4 days, take as soon as remembered; if more than 4 days, skip and resume schedule. Section 16: storage — refrigerate 2–8°C, may store at room temperature up to 30°C for 21 days.